Source: American Journal of Respiratory and Critical Care Medicine. Conference titles: American Thoracic Society International Conference (ATS). Unidade: FMRP
Subjects: ASMA, MODELOS ANIMAIS DE DOENÇAS, CITOCINAS, SACCHAROMYCES, FÁRMACOS (SISTEMA RESPIRATÓRIO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Marcos de Carvalho et al. Saccharomyces Cerevisiae Ufmg 905 modulates cytokine production in the cecum and inhibits lung inflammation in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2016APA
Borges, M. de C., Fonseca, V. M., Sandy, C., Martins, F. S., & Vianna, E. dos S. O. (2016). Saccharomyces Cerevisiae Ufmg 905 modulates cytokine production in the cecum and inhibits lung inflammation in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Borges M de C, Fonseca VM, Sandy C, Martins FS, Vianna E dos SO. Saccharomyces Cerevisiae Ufmg 905 modulates cytokine production in the cecum and inhibits lung inflammation in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine. 2016 ; 193[citado 2024 nov. 11 ]Vancouver
Borges M de C, Fonseca VM, Sandy C, Martins FS, Vianna E dos SO. Saccharomyces Cerevisiae Ufmg 905 modulates cytokine production in the cecum and inhibits lung inflammation in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine. 2016 ; 193[citado 2024 nov. 11 ]
